Physician profile
Suhail K Kanchwala
NPI 1174689038
$1,412,198.12
in general payments reported to CMS, 2019-2025
17 companies · $352K in 2025
The $352K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $111K · 2021: $97K · 2022: $209K · 2023: $262K · 2024: $335K · 2025: $352K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $914K · Travel and Lodging: $26K · Food and Beverage: $4,208 · Honoraria: $3,850 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $913,725.51 |
| Travel and Lodging | $26,476.00 |
| Food and Beverage | $4,207.55 |
| Honoraria | $3,850.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $809.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $798,529.63 | 2021-2025 | |
| Sientra, INC. | $358,209.80 | 2019-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Integra Lifesciences Corporation | $95,768.60 | 2023-2025 | Surgimend, Codman Certas, Integra |
| Surgical Innovation Associates, INC. | $42,000.00 | 2022 | |
| Kci USA, INC. | $37,518.34 | 2021-2023 | Prevena, V.A.C. Veraflo, Prevena Restor Bellaform |
| Axogen | $26,796.88 | 2019-2024 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Solventum Corporation | $25,405.52 | 2024-2025 | V.A.C. Veraflo, Prevena, Promogran Prisma |
| Allergan, INC. | $20,350.39 | 2019-2022 | |
| Davol INC. | $5,411.11 | 2019-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $812.42 | 2020 | |
| Tela Bio, INC. | $517.80 | 2021-2024 | Ovitex 2s |
| Abbvie INC. | $314.99 | 2024 | |
| Mentor Worldwide LLC | $276.62 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Becton, Dickinson and Company | $180.24 | 2025 | Phasix Mesh |
| Baxter Healthcare | $55.76 | 2024 | Tisseel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $25.26 | 2024 | |
| Medtronic, INC. | $24.76 | 2025 | Rapidvac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suhail Kanchwala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.